Cargando…

Generation of Healthy Mice from Gene-Corrected Disease-Specific Induced Pluripotent Stem Cells

Using the murine model of tyrosinemia type 1 (fumarylacetoacetate hydrolase [FAH] deficiency; FAH (−/−) mice) as a paradigm for orphan disorders, such as hereditary metabolic liver diseases, we evaluated fibroblast-derived FAH (−/−)-induced pluripotent stem cells (iPS cells) as targets for gene corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Guangming, Liu, Na, Rittelmeyer, Ina, Sharma, Amar Deep, Sgodda, Malte, Zaehres, Holm, Bleidißel, Martina, Greber, Boris, Gentile, Luca, Han, Dong Wook, Rudolph, Cornelia, Steinemann, Doris, Schambach, Axel, Ott, Michael, Schöler, Hans R., Cantz, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134447/ https://www.ncbi.nlm.nih.gov/pubmed/21765802 http://dx.doi.org/10.1371/journal.pbio.1001099

Ejemplares similares

Comparison of the activity and pluripotency maintaining potential of human leukemia inhibitory factor (LIF) produced in E.coli and CHO cells
por: Haake, Claas, et al.
Publicado: (2011)

Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
por: Eggenschwiler, Reto, et al.
Publicado: (2011)

Synthetic Notch-Receptor-Mediated Transmission of a Transient Signal into Permanent Information via CRISPR/Cas9-Based Genome Editing
por: Sgodda, Malte, et al.
Publicado: (2020)

Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)
por: Thiesler, Christina T., et al.
Publicado: (2016)

Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate
por: Marthaler, Adele G., et al.
Publicado: (2013)

Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells
por: Grabundzija, Ivana, et al.
Publicado: (2013)

Factor-Reduced Human Induced Pluripotent Stem Cells Efficiently Differentiate into Neurons Independent of the Number of Reprogramming Factors
por: Hermann, Andreas, et al.
Publicado: (2016)

Small Molecule-Assisted, Line-Independent Maintenance of Human Pluripotent Stem Cells in Defined Conditions
por: Frank, Stefan, et al.
Publicado: (2012)

Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions
por: Joo, Jin Young, et al.
Publicado: (2014)

ERRATUM: Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions
por: Joo, Jin Young, et al.
Publicado: (2015)

Establishment of feeder-free culture system for human induced pluripotent stem cell on DAS nanocrystalline graphene
por: Lee, Hyunah, et al.
Publicado: (2016)

Chemically-Defined, Xeno-Free, Scalable Production of hPSC-Derived Definitive Endoderm Aggregates with Multi-Lineage Differentiation Potential
por: Sahabian, Anais, et al.
Publicado: (2019)

The Role of microRNAs in Embryonic and Induced Pluripotency
por: Beh-Pajooh, Abbas, et al.
Publicado: (2018)

The PluriNetWork: An Electronic Representation of the Network Underlying Pluripotency in Mouse, and Its Applications
por: Som, Anup, et al.
Publicado: (2010)

Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy
por: Schleidgen, Sebastian, et al.
Publicado: (2020)

Regulation of Liver Enriched Transcription Factors in Rat Hepatocytes Cultures on Collagen and EHS Sarcoma Matrices
por: Borlak, Jürgen, et al.
Publicado: (2015)

MicroRNA-125b-5p mimic inhibits acute liver failure
por: Yang, Dakai, et al.
Publicado: (2016)

A modified TALEN-based system for robust generation of knock-out human pluripotent stem cell lines and disease models
por: Frank, Stefan, et al.
Publicado: (2013)

Back to pluripotency: fully chemically induced reboot of human somatic cells
por: Lange, Lucas, et al.
Publicado: (2022)

Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs
por: Illich, Damir Jacob, et al.
Publicado: (2016)

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model
por: Rahman, Shamim H., et al.
Publicado: (2015)

Zfp296 Is a Novel, Pluripotent-Specific Reprogramming Factor
por: Fischedick, Gerrit, et al.
Publicado: (2012)

MicroRNA‐125b‐5p Regulates Hepatocyte Proliferation During the Termination Phase of Liver Regeneration
por: Yang, Dakai, et al.
Publicado: (2020)

Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase
por: Eggenschwiler, Reto, et al.
Publicado: (2016)

Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein
por: Ehrlich, Marc, et al.
Publicado: (2015)

Residual pluripotency is required for inductive germ cell segregation
por: Aramaki, Shinya, et al.
Publicado: (2021)

Human pluripotent stem cell-derived cardiomyocytes: Genome-wide expression profiling of long-term in vitro maturation in comparison to human heart tissue
por: Piccini, Ilaria, et al.
Publicado: (2015)

bHLH Transcription Factor Math6 Antagonizes TGF-β Signalling in Reprogramming, Pluripotency and Early Cell Fate Decisions
por: Divvela, Satya Srirama Karthik, et al.
Publicado: (2019)

Kindlin-2 Modulates the Survival, Differentiation, and Migration of Induced Pluripotent Cell-Derived Mesenchymal Stromal Cells
por: Moslem, Mohsen, et al.
Publicado: (2017)

Enhanced Ex Vivo Generation of Erythroid Cells from Human Induced Pluripotent Stem Cells in a Simplified Cell Culture System with Low Cytokine Support
por: Bernecker, Claudia, et al.
Publicado: (2019)

Electrophysiological Properties of Tetraploid Cardiomyocytes Derived from Murine Pluripotent Stem Cells Generated by Fusion of Adult Somatic Cells with Embryonic Stem Cells
por: Xu, Guoxing, et al.
Publicado: (2023)

CRISPR/Cas9 Genome Editing in LGMD2A/R1 Patient-Derived Induced Pluripotent Stem and Skeletal Muscle Progenitor Cells
por: Mavrommatis, Lampros, et al.
Publicado: (2023)

Stem cells in liver regeneration and therapy
por: Cantz, Tobias, et al.
Publicado: (2007)

Cardiogenic programming of human pluripotent stem cells by dose-controlled activation of EOMES
por: Pfeiffer, Martin J., et al.
Publicado: (2018)

Counteracting Activities of OCT4 and KLF4 during Reprogramming to Pluripotency
por: Tiemann, Ulf, et al.
Publicado: (2014)

Homogeneity of XEN Cells Is Critical for Generation of Chemically Induced Pluripotent Stem Cells
por: Jeong, Dahee, et al.
Publicado: (2023)

Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction
por: Moslem, Mohsen, et al.
Publicado: (2015)

p53 connects tumorigenesis and reprogramming to pluripotency
por: Tapia, Natalia, et al.
Publicado: (2010)

Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations
por: Moradi, Sharif, et al.
Publicado: (2019)

A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines
por: Eggenschwiler, Reto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtqggd00u7g1nf83u09m8adh96